戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1           Patients received conformal RT, or intensity modulated radiation therapy.
2 tic radical prostatectomy, or photon-beam or intensity-modulated radiation therapy.
3 stasis remains a significant problem despite intensity-modulated radiation therapy.
4 phic imaging for beam delivery planning, and intensity-modulated radiation therapy.
5                                              Intensity-modulated radiation therapy, a specific form o
6                          The introduction of intensity modulated radiation therapy and biological age
7                                              Intensity modulated radiation therapy appears to be a pr
8                   Techniques for preclinical intensity modulated radiation therapy are being develope
9  cell carcinoma treated with curative-intent intensity-modulated radiation therapy between August 201
10  trial comparing conventionally fractionated intensity-modulated radiation therapy (CIMRT, 75.6 Gy in
11  Gy per fraction (conventional fractionation intensity-modulated radiation therapy [CIMRT]) versus 70
12 days 1, 22, and 43 of radiation (70 Gy) with intensity-modulated radiation therapy delivered over 33
13      Recent studies have started to evaluate intensity modulated radiation therapy for anal cancer, i
14 ating the multi-institutional feasibility of intensity modulated radiation therapy for anal cancer.
15 adjusted rates of 3-dimensional conformal or intensity-modulated radiation therapy for prostate cance
16 e (BCDF) rate with moderate hypofractionated intensity-modulated radiation therapy (H-IMRT) versus co
17                                              Intensity-modulated radiation therapy has undergone a ra
18 and anal cancer (chemoradiation and possibly intensity-modulated radiation therapy) have been encoura
19                 Single-fraction image-guided intensity-modulated radiation therapy (IG-IMRT) allows f
20 ts in the field of radiation therapy-such as intensity-modulated radiation therapy, image-guided radi
21  treatment, such as robotic surgery, dynamic intensity-modulated radiation therapy, immunotherapy, an
22 ck cancer (HNC) treated with curative-intent intensity-modulated radiation therapy (IMRT) (>=45 Gy) f
23 atients with primary-site cCR to IC received intensity-modulated radiation therapy (IMRT) 54 Gy with
24 ded stereotactic body radiotherapy (SBRT) or intensity-modulated radiation therapy (IMRT) after all i
25                                              Intensity-modulated radiation therapy (IMRT) and image-g
26                                              Intensity-modulated radiation therapy (IMRT) and laparos
27 option of newer radiation treatments such as intensity-modulated radiation therapy (IMRT) and proton
28 s in patients who were undergoing definitive intensity-modulated radiation therapy (IMRT) for localiz
29 like for locally advanced NSCLC, the role of intensity-modulated radiation therapy (IMRT) for PORT re
30 e are able to accurately predict the dose of intensity-modulated radiation therapy (IMRT) for prostat
31 t of proton beam therapy (PBT) compared with intensity-modulated radiation therapy (IMRT) for prostat
32                          The introduction of intensity-modulated radiation therapy (IMRT) in the earl
33                                   The use of intensity-modulated radiation therapy (IMRT) in the trea
34                             Purpose Although intensity-modulated radiation therapy (IMRT) is increasi
35                    One of the concerns about intensity-modulated radiation therapy (IMRT) is that its
36                                              Intensity-modulated radiation therapy (IMRT) reirradiati
37                                              Intensity-modulated radiation therapy (IMRT) represents
38          This study compared the toxicity of intensity-modulated radiation therapy (IMRT) to the pros
39                                   Five-field intensity-modulated radiation therapy (IMRT) was then us
40          Some urology groups have integrated intensity-modulated radiation therapy (IMRT), a radiatio
41 urrent state-of-the-art photon radiotherapy, intensity-modulated radiation therapy (IMRT), has prompt
42 ere treated at diagnosis with brachytherapy, intensity-modulated radiation therapy (IMRT), or radical
43 er treatment that may be less expensive than intensity-modulated radiation therapy (IMRT).
44 er patients with concurrent chemotherapy and intensity-modulated radiation therapy (IMRT).
45 ith proton beam versus 81 CGE delivered with intensity-modulated radiation therapy (IMRT).
46 en with modern radiation techniques, such as intensity-modulated radiation therapy (IMRT).
47 effects, even with modern techniques such as intensity-modulated radiation therapy (IMRT).
48 ning systems, stereotactic radiosurgery, and intensity modulated radiation therapy in radiation oncol
49                                              Intensity-modulated radiation therapy is an advanced for
50 y in 3 fractions, EQD2 43 Gy), 65% underwent intensity-modulated radiation therapy (median 53 Gy in 2
51 tion technique, the panel recommended use of intensity-modulated radiation therapy or proton therapy
52 as given in 2 Gy daily fractions with either intensity-modulated radiation therapy or three-dimension
53                    Treatment (brachytherapy, intensity-modulated radiation therapy, or radical prosta
54                                              Intensity-modulated radiation therapy patients were less
55 oral surgical techniques and the adoption of intensity-modulated radiation therapy planning have been
56 e-dimensional conformal radiation therapy or intensity-modulated radiation therapy/rotational techniq
57 ve been advances in each modality, including intensity-modulated radiation therapy, sequential chemot
58 rnatives, such as liposomal doxorubicin, and intensity-modulated radiation therapy should be consider
59  analysis comparing proton beam therapy with intensity-modulated radiation therapy showed significant
60                                              Intensity-modulated radiation therapy to 70 Gy at 2 Gy/f
61 esophageal cancer (EC) patients administered intensity-modulated radiation therapy with simultaneous